Bayer Detailed Consensus >> Segments
Last Update: 2020-06-30

Please note:

All 2019 figures were re-based to reflect the change in cost allocations from enabling functions to the divisions effective Jan. 1, 2020.


KPI[EUR m]FY 2019FY 2020 EFY 2021 EFY 2022 EFY 2023 EFY 2024 E
Pharmaceuticals, SalesNumber of Estimates1817151412
Pharmaceuticals, SalesHighest18,73819,64720,64821,51222,173
Pharmaceuticals, SalesAverage17,96218,33419,07019,73619,80519,077
Pharmaceuticals, SalesMedian18,38019,10019,68619,81219,074
Pharmaceuticals, SalesLowest17,70617,90418,40917,59117,030
XareltoNumber of Estimates1211101010
XareltoHighest4,6935,3345,8546,4096,526
XareltoAverage4,1264,5905,0535,4195,2874,349
XareltoMedian4,5855,0405,3825,5284,048
XareltoLowest4,4434,7695,1163,9092,713
EyleaNumber of Estimates1211101010
EyleaHighest2,7132,9843,2533,5133,759
EyleaAverage2,4942,5512,7292,7322,6812,589
EyleaMedian2,5702,6742,7442,6472,446
EyleaLowest2,0762,4692,4002,2001,990
Mirena product familyNumber of Estimates1110101010
Mirena product familyHighest1,3301,3311,3891,4351,492
Mirena product familyAverage1,2231,2601,2831,2951,3131,326
Mirena product familyMedian1,2571,2981,3511,3821,381
Mirena product familyLowest1,2101,1851,007906816
Kogenate (incl. Kovaltry, Jivi)Number of Estimates1211101010
Kogenate (incl. Kovaltry, Jivi)Highest1,0291,0391,034964983
Kogenate (incl. Kovaltry, Jivi)Average882903877835798766
Kogenate (incl. Kovaltry, Jivi)Median898875847821794
Kogenate (incl. Kovaltry, Jivi)Lowest830734622541481
NexavarNumber of Estimates1111101010
NexavarHighest663558481446419
NexavarAverage706575400280210170
NexavarMedian600476298197158
NexavarLowest439108866955
Pharmaceuticals, EBITDA before special itemsNumber of Estimates1716141311
Pharmaceuticals, EBITDA before special itemsHighest6,3226,7517,1607,7797,827
Pharmaceuticals, EBITDA before special itemsAverage5,8616,1076,5006,8436,9336,486
Pharmaceuticals, EBITDA before special itemsMedian6,1046,5086,8486,9486,583
Pharmaceuticals, EBITDA before special itemsLowest5,9346,2896,5165,8365,309
Consumer Health, SalesNumber of Estimates1817151412
Consumer Health, SalesHighest5,7295,6825,7585,9126,049
Consumer Health, SalesAverage5,4625,3745,4455,5615,7115,838
Consumer Health, SalesMedian5,3585,4505,5695,7365,868
Consumer Health, SalesLowest5,1235,1455,2495,3435,438
Consumer Health, EBITDA before special itemsNumber of Estimates1716141311
Consumer Health, EBITDA before special itemsHighest1,2311,2941,3781,4601,493
Consumer Health, EBITDA before special itemsAverage1,1421,1871,2401,3091,3611,400
Consumer Health, EBITDA before special itemsMedian1,1921,2421,3171,3611,407
Consumer Health, EBITDA before special itemsLowest1,1221,1831,2071,2561,278
CropScience, SalesNumber of Estimates1817151412
CropScience, SalesHighest20,68521,57422,35423,37624,077
CropScience, SalesAverage19,83220,26220,94221,58922,26622,870
CropScience, SalesMedian20,34921,04521,75322,30622,914
CropScience, SalesLowest19,58619,98520,63220,94421,262
CropScience, EBITDA before special itemsNumber of Estimates1716141311
CropScience, EBITDA before special itemsHighest5,5946,1536,9647,2417,593
CropScience, EBITDA before special itemsAverage4,7145,2875,8106,3906,6296,895
CropScience, EBITDA before special itemsMedian5,2875,8576,4306,7427,067
CropScience, EBITDA before special itemsLowest5,0105,4565,7855,4425,575
Reconciliation, SalesNumber of Estimates1817151413
Reconciliation, SalesHighest301390389389389
Reconciliation, SalesAverage289278287293295297
Reconciliation, SalesMedian289289289289289
Reconciliation, SalesLowest220220249249249
Reconciliation, EBITDA before special itemsNumber of Estimates1716141312
Reconciliation, EBITDA before special itemsHighest-1150000
Reconciliation, EBITDA before special itemsAverage-245-307-275-285-313-339
Reconciliation, EBITDA before special itemsMedian-345-325-302-340-322
Reconciliation, EBITDA before special itemsLowest-400-358-358-673-1,013
Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.